Unknown

Dataset Information

0

Do the Morningness-Eveningness Questionnaire and Munich ChronoType Questionnaire Change After Morning Light Treatment?


ABSTRACT: The Morningness-Eveningness Questionnaire (MEQ) and Munich ChronoType Questionnaire (MCTQ) are sometimes used to estimate circadian timing. However, it remains unclear if they can reflect a change in circadian timing after a light treatment. In this study, 31 participants (25-68 years) completed both questionnaires before and after a 13-28 day morning light treatment. The dim light melatonin onset (DLMO), a physiological marker of circadian timing, was also assessed in a subsample of 16 participants. The DLMO phase advanced on average by 47 minutes (p<0.001). The MEQ score increased by 1.8 points (p=0.046). The MSFsc measure derived from the MCTQ advanced by 8.7 minutes (p=0.17). The shift towards morningness observed in both questionnaires correlated with the phase advance observed in the DLMO (MEQ r=-0.46, p=0.036; MSFsc r=0.81, p<0.001). Results suggest that these circadian questionnaires can change in response to a light treatment, indicating they can reflect underlying changes in circadian timing.

SUBMITTER: Burgess HJ 

PROVIDER: S-EPMC6615569 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Do the Morningness-Eveningness Questionnaire and Munich ChronoType Questionnaire Change After Morning Light Treatment?

Burgess Helen J HJ   Kikyo Fumitaka F   Valdespino-Hayden Zerbrina Z   Rizvydeen Muneer M   Kimura Momoko M   Pollack Mark H MH   Hobfoll Stevan E SE   Rajan Kumar B KB   Zalta Alyson K AK   Burns John W JW  

Sleep science and practice 20180916


The Morningness-Eveningness Questionnaire (MEQ) and Munich ChronoType Questionnaire (MCTQ) are sometimes used to estimate circadian timing. However, it remains unclear if they can reflect a change in circadian timing after a light treatment. In this study, 31 participants (25-68 years) completed both questionnaires before and after a 13-28 day morning light treatment. The dim light melatonin onset (DLMO), a physiological marker of circadian timing, was also assessed in a subsample of 16 particip  ...[more]

Similar Datasets

| S-EPMC6695085 | biostudies-literature
| S-EPMC6438473 | biostudies-literature
| S-EPMC9344083 | biostudies-literature
| S-EPMC6051639 | biostudies-literature
| S-EPMC4315718 | biostudies-other
| S-EPMC8285513 | biostudies-literature
| S-EPMC10171641 | biostudies-literature
| S-EPMC7372122 | biostudies-literature
| S-EPMC6344426 | biostudies-literature
| S-EPMC5206670 | biostudies-literature